-
1
-
-
0028103748
-
Haemolytic uraemic syndrome: Basic science
-
Moake Lawrence Joel. Haemolytic uraemic syndrome: Basic Science. Lancet 1994; 343: 393-397
-
(1994)
Lancet
, vol.343
, pp. 393-397
-
-
Moake, L.J.1
-
2
-
-
0025999820
-
Improved survival in thrombotic thrombocytopenic purpura haemolytic-uraemic syndrome - Clinical experience in 108 patients
-
Bell WR, Braine HG, Ness PM, Kickler TS. Improved survival in thrombotic thrombocytopenic purpura haemolytic-uraemic syndrome - clinical experience in 108 patients. N Engl J Med 1991; 325: 398-402
-
(1991)
N Engl J Med
, vol.325
, pp. 398-402
-
-
Bell, W.R.1
Braine, H.G.2
Ness, P.M.3
Kickler, T.S.4
-
3
-
-
0023515596
-
Haemolytic uraemic syndrome associated with cisplatin therapy
-
Weinblalt ME, Kahn E et al. Haemolytic uraemic syndrome associated with cisplatin therapy. Am J Paediatr Haematol Oncol 1987; 9: 295-298
-
(1987)
Am J Paediatr Haematol Oncol
, vol.9
, pp. 295-298
-
-
Weinblalt, M.E.1
Kahn, E.2
-
4
-
-
0021718985
-
Detection of a platelet agglutinating factor in thrombotic and thrombocytopenic purpura
-
Kelton JG et al. Detection of a platelet agglutinating factor in thrombotic and thrombocytopenic purpura. Ann Intern Med 1984; 101: 589
-
(1984)
Ann Intern Med
, vol.101
, pp. 589
-
-
Kelton, J.G.1
-
5
-
-
0018076111
-
HUS: Deficiency of plasma factor(s) regulating prostacyclin activity?
-
Remuzzi G et al. HUS: deficiency of plasma factor(s) regulating prostacyclin activity? Lancet 1978; 2: 871
-
(1978)
Lancet
, vol.2
, pp. 871
-
-
Remuzzi, G.1
-
6
-
-
0019969645
-
Abnormal prostacyclin metabolism in the HUS: Equivocal effect of prostacyclin infusion
-
Defreyn G et al. Abnormal prostacyclin metabolism in the HUS: Equivocal effect of prostacyclin infusion. Clin Nephrol 1982; 18: 43
-
(1982)
Clin Nephrol
, vol.18
, pp. 43
-
-
Defreyn, G.1
-
7
-
-
0019469226
-
Accelerated prostacyclin degradation in thrombotic thrombocytopenic purpura
-
Chen YC et al. Accelerated prostacyclin degradation in thrombotic thrombocytopenic purpura. Lancet 1981; 2: 267
-
(1981)
Lancet
, vol.2
, pp. 267
-
-
Chen, Y.C.1
-
8
-
-
0020428664
-
Unusually large plasma factor VIII: Von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura
-
Moake JL et al. Unusually large plasma factor VIII: Von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Eng J Med 1982; 307: 1432
-
(1982)
N Eng J Med
, vol.307
, pp. 1432
-
-
Moake, J.L.1
-
9
-
-
0022351357
-
Elevated plasma Von Willebrand factor levels and arterial occlusive complications associated with cisplatin based chemotherapy
-
Licciardello JTW, Moake JL, Rudyck et al. Elevated plasma Von Willebrand factor levels and arterial occlusive complications associated with cisplatin based chemotherapy. Oncology 1985; 42: 246-300
-
(1985)
Oncology
, vol.42
, pp. 246-300
-
-
Licciardello, J.T.W.1
Moake, J.L.2
Rudyck3
-
10
-
-
0024391413
-
Cancer associated haemolytic uraemic syndrome: Analysis of 85 cases from a national registry
-
Lesesne JB, Rothschild N, Erickson B. et al. Cancer associated haemolytic uraemic syndrome: Analysis of 85 cases from a national registry. J Clin Oncol 1989; 7: 781-789
-
(1989)
J Clin Oncol
, vol.7
, pp. 781-789
-
-
Lesesne, J.B.1
Rothschild, N.2
Erickson, B.3
-
11
-
-
0024817270
-
Haemolytic uraemic syndrome following cisplatin, bleomycin and vincristine chemotherapy: A report of a case and review of literature
-
Gardner G, Mesler D, Gitelman HJ. Haemolytic uraemic syndrome following cisplatin, bleomycin and vincristine chemotherapy: A report of a case and review of literature. Renal Failure 1989; 11: 133-137
-
(1989)
Renal Failure
, vol.11
, pp. 133-137
-
-
Gardner, G.1
Mesler, D.2
Gitelman, H.J.3
-
12
-
-
0021195844
-
Thrombotic microangiopathy and renal failure associated with antineoplastic chemotherapy
-
Jackson AM, Rose BD. Thrombotic microangiopathy and renal failure associated with antineoplastic chemotherapy. Ann Intern Med 1984; 101: 41-44
-
(1984)
Ann Intern Med
, vol.101
, pp. 41-44
-
-
Jackson, A.M.1
Rose, B.D.2
-
13
-
-
0019985502
-
Renal vascular lesions after chemotherapy with vinblastine, bleomycin and cisplatin
-
Harrell RM, Sibley R, Vogelz NJ. Renal vascular lesions after chemotherapy with vinblastine, bleomycin and cisplatin. Am J Med 1982; 73: 429-433
-
(1982)
Am J Med
, vol.73
, pp. 429-433
-
-
Harrell, R.M.1
Sibley, R.2
Vogelz, N.J.3
-
14
-
-
0028035370
-
Cisplatin associated haemolytic uraemic syndrome
-
Canpolat C, Pearson P, Jaffe N. Cisplatin associated haemolytic uraemic syndrome. Cancer 1994; 74: 3059-3062
-
(1994)
Cancer
, vol.74
, pp. 3059-3062
-
-
Canpolat, C.1
Pearson, P.2
Jaffe, N.3
-
15
-
-
0344168893
-
Carcinoma associated haemolytic uraemic syndrome: A complication of mitomycin chemotherapy
-
Cantrell JE, Philips TM, Schein PS. Carcinoma associated haemolytic uraemic syndrome: a complication of mitomycin chemotherapy. J Clin Oncol 1995; 3:
-
(1995)
J Clin Oncol
, vol.3
-
-
Cantrell, J.E.1
Philips, T.M.2
Schein, P.S.3
-
16
-
-
0022196949
-
Haemolytic uraemic syndrome in a patient on cisplatinum, vinblastine and bleomycin
-
Vandeer Meer J, de Vries EGE, Vriesendorp R. et al. Haemolytic uraemic syndrome in a patient on cisplatinum, vinblastine and bleomycin. J Cancer Res Clin Oncol 1985; 110: 119-122
-
(1985)
J Cancer Res Clin Oncol
, vol.110
, pp. 119-122
-
-
Vandeer Meer, J.1
De Vries, E.G.E.2
Vriesendorp, R.3
-
17
-
-
0021044575
-
Mechanism of cisplatin nephrotoxicity
-
Weiner MW, Jacobs C. Mechanism of cisplatin nephrotoxicity. Federation Proc 1983; 42: 2974-2978
-
(1983)
Federation Proc
, vol.42
, pp. 2974-2978
-
-
Weiner, M.W.1
Jacobs, C.2
-
18
-
-
0019521189
-
Raynaud's phenomenon: A common toxicity after combination chemotherapy for testicular cancer
-
Vogelzang NJ, Bosl GJ, Johnson K, Kennedy BJ. Raynaud's phenomenon: A common toxicity after combination chemotherapy for testicular cancer. Ann Intern Med 1981; 95: 288-292
-
(1981)
Ann Intern Med
, vol.95
, pp. 288-292
-
-
Vogelzang, N.J.1
Bosl, G.J.2
Johnson, K.3
Kennedy, B.J.4
-
19
-
-
0022606825
-
Treatment of cancer associated haemolytic uraemic syndrome with staphylococcal protein A immunoperfusion
-
Korec S, Schein PS, Smith FP et al. Treatment of cancer associated haemolytic uraemic syndrome with staphylococcal protein A immunoperfusion. J Clin Oncol 1986; 4: 210-215
-
(1986)
J Clin Oncol
, vol.4
, pp. 210-215
-
-
Korec, S.1
Schein, P.S.2
Smith, F.P.3
-
20
-
-
0024450949
-
Cisplatin associated haemolytic uraemic syndrome. Successful treatment with a staphylococcal Protein A column
-
Watson PR, Guthrie TH Jr, Caruana RJ. Cisplatin associated haemolytic uraemic syndrome. Successful treatment with a staphylococcal Protein A column. Cancer 1989; 64: 1400-1403
-
(1989)
Cancer
, vol.64
, pp. 1400-1403
-
-
Watson, P.R.1
Guthrie T.H., Jr.2
Caruana, R.J.3
-
21
-
-
0021353942
-
Influence of platinum induced renal toxicity on bleomycin induced pulmonary toxicity in patients with disseminated testicular carcinoma
-
Van Barneveld DWC, Sleijfer DT, Vander Mark TW et al. Influence of platinum induced renal toxicity on bleomycin induced pulmonary toxicity in patients with disseminated testicular carcinoma. Oncology 1984; 41: 4-7
-
(1984)
Oncology
, vol.41
, pp. 4-7
-
-
Van Barneveld, D.W.C.1
Sleijfer, D.T.2
Vander Mark, T.W.3
|